Catalent Pharma Solutions

March 1, 2019
Sponsored Content

Catalent Biologics’ Bloomington, Indiana facility provides sterile formulation and extensive biomanufacturing and drug product fill/finish capacity across a number of biological drug product formats.

Catalent Biologics’ Bloomington, Indiana facility provides sterile formulation and extensive biomanufacturing and drug product fill/finish capacity across a number of biological drug product formats.

The site recently achieved regulatory approval for a 20th commercial product, and investment of more than $100 million has been announced to expand manufacturing and packaging capabilities, increasing flexibility and capacity.

Catalent
INTERPHEX Booth #1145